Pharmacological risk factors for amphotericin B nephrotoxicity in children.
Goldman
Ran D
RD
Pediatric Research in Emergency Therapeutics Program, Division of Pediatric Emergency Medicine, Department of Pediatrics, BC Children's Hospital, University of British Columbia, 4480 Oak Street, Vancouver, BC V6H 3V4, Canada. rgoldman@cw.bc.ca
Ong
Michael
M
Wolpin
Jacob
J
Doyle
John
J
Parshuram
Christopher
C
Koren
Gideon
G
D000293:Adolescent; D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors
D000935:Antifungal Agents; D000666:Amphotericin B; D003404:Creatinine